837 hedge funds and large institutions have $11.6B invested in GSK in 2024 Q4 according to their latest regulatory filings, with 105 funds opening new positions, 283 increasing their positions, 319 reducing their positions, and 149 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more ownership

Funds ownership:

less funds holding

Funds holding:

9% less capital invested

Capital invested by funds: $12.7B → $11.6B (-$1.08B)

11% less repeat investments, than reductions

Existing positions increased: 283 | Existing positions reduced: 319

30% less first-time investments, than exits

New positions opened: 105 | Existing positions closed: 149

Holders
837
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$460M
Puts
$105M
Net Calls
Net Calls Change

Top Buyers

1 +$805M
2 +$352M
3 +$197M
4
Goldman Sachs
Goldman Sachs
New York
+$78.2M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$68.2M

Top Sellers

1 -$162M
2 -$123M
3 -$92.9M
4
HSBC Holdings
HSBC Holdings
United Kingdom
-$86M
5
Morgan Stanley
Morgan Stanley
New York
-$75.3M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$67M
27
$63.9M
28
$59.5M
29
$55.1M
30
$54.9M
31
$54.2M
32
$54M
33
$52.3M
34
$48.8M
35
$46.8M
36
$46M
37
$45.8M
38
$44.6M
39
$44.6M
40
$42.5M
41
$36.7M
42
$36.4M
43
$35.9M
44
$34.7M
45
$34.6M
46
$33.8M
47
$32.9M
48
$31.2M
49
$29.9M
50
$28.5M